These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 1977185)

  • 1. Sulphasalazine and the aminosalicylates in the treatment of inflammatory bowel disease.
    Riley SA; Turnberg LA
    Q J Med; 1990 Jun; 75(278):551-62. PubMed ID: 1977185
    [No Abstract]   [Full Text] [Related]  

  • 2. Aminosalicylates: old and new.
    Hanauer SB
    Mt Sinai J Med; 1990 Oct; 57(5):283-7. PubMed ID: 1982892
    [No Abstract]   [Full Text] [Related]  

  • 3. [New salicylic acid derivatives in the treatment of inflammatory intestinal diseases].
    Kovács A
    Orv Hetil; 1991 Jun; 132(24):1317-21. PubMed ID: 1677465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [New derivates of salazopyrine in the treatment of chronic inflammatory bowel disease].
    Broide E; Scapa E; Abramowich D; Eshchar Y
    Harefuah; 1993 Feb; 124(4):223-5. PubMed ID: 8098698
    [No Abstract]   [Full Text] [Related]  

  • 5. [Salicylic derivatives in the clinical treatment of inflammatory bowel disease: new perspectives].
    Damião AO; Sipahi AM
    Rev Hosp Clin Fac Med Sao Paulo; 1989; 44(5):271-8. PubMed ID: 2576896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drug treatment and formation of eicosanoids in patients with chronic inflammatory bowel disease.
    Lauritsen K
    Dan Med Bull; 1989 Sep; 36(4):378-93. PubMed ID: 2572403
    [No Abstract]   [Full Text] [Related]  

  • 7. [5-ASA versus sulfasalazine].
    Varela E
    Acta Gastroenterol Latinoam; 1994; 25(5):317-9. PubMed ID: 7785405
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug insight: aminosalicylates for the treatment of IBD.
    Nielsen OH; Munck LK
    Nat Clin Pract Gastroenterol Hepatol; 2007 Mar; 4(3):160-70. PubMed ID: 17339853
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Experiences with phase III studies in the area of gastroenterology].
    Kruis W
    Verh Dtsch Ges Inn Med; 1991; 97():503-6. PubMed ID: 1687301
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aminosalicylates in the treatment of idiopathic inflammatory bowel disease].
    Lukás K
    Vnitr Lek; 1996 Feb; 42(2):117-9. PubMed ID: 8686186
    [No Abstract]   [Full Text] [Related]  

  • 11. Renal tubular damage: an extraintestinal manifestation of chronic inflammatory bowel disease.
    Kreisel W; Wolf LM; Grotz W; Grieshaber M
    Eur J Gastroenterol Hepatol; 1996 May; 8(5):461-8. PubMed ID: 8804875
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminosalicylates and colorectal cancer in IBD: a not-so bitter pill to swallow.
    Ryan BM; Russel MG; Langholz E; Stockbrugger RW
    Am J Gastroenterol; 2003 Aug; 98(8):1682-7. PubMed ID: 12907319
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Update on the aminosalicylates: a promise fulfilled.
    Peppercorn MA
    Gastroenterology; 1988 Dec; 95(6):1677-80. PubMed ID: 2903113
    [No Abstract]   [Full Text] [Related]  

  • 14. Effects of aminosalicylates on thiopurine S-methyltransferase activity: an ex vivo study in patients with inflammatory bowel disease.
    Xin H; Fischer C; Schwab M; Klotz U
    Aliment Pharmacol Ther; 2005 May; 21(9):1105-9. PubMed ID: 15854172
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inflammatory bowel disease.
    Van Rosendaal GM
    CMAJ; 1989 Jul; 141(2):113-23; discussion 123-4. PubMed ID: 2568163
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory bowel diseases, 5-aminosalicylic acid and sulfasalazine treatment and risk of acute pancreatitis: a population-based case-control study.
    Munk EM; Pedersen L; Floyd A; Nørgård B; Rasmussen HH; Sørensen HT
    Am J Gastroenterol; 2004 May; 99(5):884-8. PubMed ID: 15128355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacologic therapy for inflammatory bowel disease.
    Hirschfeld S; Clearfield HR
    Am Fam Physician; 1995 Jun; 51(8):1971-5. PubMed ID: 7762487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prescriptions for mesalazine and sulphasalazine: a prevalence estimate of patients treated for inflammatory bowel disease in Rome.
    Tebano MT; Traversa G; Da Cas R; Loizzo A
    Aliment Pharmacol Ther; 1996 Aug; 10(4):659-63. PubMed ID: 8853773
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Arachidonic acid metabolism and intracellular calcium concentration in inflammatory bowel disease.
    Schmidt C; Kosché E; Baumeister B; Vetter H
    Eur J Gastroenterol Hepatol; 1995 Sep; 7(9):865-9. PubMed ID: 8574719
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Controversies with aminosalicylates in inflammatory bowel disease.
    Lim WC; Hanauer SB
    Rev Gastroenterol Disord; 2004; 4(3):104-17. PubMed ID: 15359211
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.